Find Academic Supervisors

• Medical Imaging
• Ultrasound
• Oncology
• +3 more

Marie Kristina Rue Nielsen serves as a Clinical Associate Professor within the Department of Clinical Medicine at the University of Copenhagen, Denmark, maintaining an active research profile in advanced medical imaging techniques. Her institutional affiliation is centered at Blegdamsvej 3, 2200 Copenhagen N, with direct ties to Region Hovmark (regionh.dk) for clinical implementation. Her research program emphasizes translational imaging solutions for oncology, specifically targeting: Sentinel lymph node mapping via contrast-enhanced ultrasound Multimodal image fusion (ultrasound/MRI) for procedural guidance Radionuclide techniques in breast cancer and melanoma diagnostics Phantom-model validation of biopsy methodologies Analysis of her publication history reveals a concentrated research trajectory from 2008-2010 focused on improving diagnostic precision in cancer staging through engineered imaging protocols. Notably, her work on ultrasound-MRI fusion and sentinel node detection has generated significant practical impact, evidenced by citations in 13 patent applications and engagement from 27 Mendeley readers. The publications demonstrate consistent collaboration with Copenhagen-based radiology teams, particularly with Michael Bachmann Nielsen's group, though no current institutional leadership roles are specified. While no formal awards or grant details appear in the source material, her research has achieved notable scholarly recognition through Scopus citations (2, 16, and 22 for her three journal articles), indicating sustained relevance in radiological oncology. The absence of student advisement records or laboratory descriptions suggests primary focus on methodological development rather than team leadership during this documented period.

• Breast Cancer
• Axillary Surgery
• Sentinel Node Procedure
• +2 more

Tove Holst Filtenborg Tvedskov holds a dual appointment as Clinical Professor at the University of Copenhagen's Faculty of Health and Medical Sciences and consultant in breast surgery at the Department of Breast Surgery, Gentofte Hospital, Capital Region of Denmark. She maintains an active clinical and research career focused on breast cancer surgery with particular emphasis on optimizing axillary procedures. Her educational background includes an MD from the University of Aarhus (1995), PhD from the University of Copenhagen (2012) on omitting axillary clearance in sentinel node micrometastases, and DMSc (dr.med.) in 2017 on the evolution of sentinel node procedures. She became a specialist in surgery in 2007 and subspecialized in breast surgery in 2013. Professor Tvedskov's research primarily focuses on de-escalating axillary surgery in breast cancer treatment. Her work centers on determining which patients can safely avoid extensive axillary lymph node dissection while maintaining optimal oncological outcomes. This research has significant implications for reducing postoperative morbidity while preserving cancer control. Analysis of her recent publications reveals a strong focus on clinical trials evaluating axillary management strategies, particularly the SENOMAC trial which examines omitting axillary dissection in sentinel node positive patients. Her work spans surgical techniques, imaging modalities for staging, and reconstruction methods, demonstrating a comprehensive approach to breast cancer care that integrates surgical oncology with plastic surgery considerations. Professor Tvedskov serves in multiple leadership roles including member of the SENOMAC trial steering committee, principal investigator for the DBCG RT RECON trial on delayed-immediate breast reconstruction, head of the national steering committee for the MELODY trial, member of the Danish Breast Cancer Group (DBCG) steering board, head of the DBCG surgical board, and member of the Nordic Breast Cancer Network (NBCN) steering group. Her research has been supported by numerous funding sources including Pink Tribute, Kræftens Bekæmpelse, ACROBATIC, Region Hovedstaden, Herlev-Gentofte Hospital, Danish Comprehensive Cancer Center, Landsforeningen mod Brystkræft, and several foundation grants. She has received travel grants from Harboefonden, Lundbeckfonden, Kræftens Bekæmpelse, Novartis Oncology, Rigshospitalet, and MSD. Professor Tvedskov is actively involved in the national and international breast cancer research community, collaborating with multiple institutions across Europe. Her work has been recognized through extensive citations, media coverage, and incorporation into clinical guidelines, demonstrating significant impact on breast cancer treatment protocols.